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The  aim  of  this  study  was to  provide  scientiﬁc  knowledge  to  support  the  use  of  Vernonia  condensata  Baker,
Asteraceae,  beverages  for  their  alleged  hypocholesterolemic  properties  by  testing  their  action  as  HMG-
CoA reductase  inhibitors  and  their  capacity  to lower  dietary  cholesterol  permeation.  Chlorogenic  acid,
and  other  caffeoylquinic  acids  derivatives  were  identiﬁed  as  the main  components  of these  beverages
by  LC–MS/MS.  No  changes  in the  composition  were  notice  after  the  in  vitro gastrointestinal  digestion
and  no  toxicity  against  Caco-2  and  HepG2  cell  lines  was  detected.  Cholesterol  permeation  through  Caco-ernonia condensata
MG-CoA reductase
hlorogenic acid
ynarin
holesterol
aco-2 cells
2 monolayers  was  reduced  in 37%  in  the  presence  of these  herbal  teas,  and  the caffeoylquinic  acids
permeated  the monolayers  in 30–40%  of their  initial  amount  in  6  h. HMG-CoA  reductase  activity was
reduced  with  these  beverages,  showing  an  IC50 of 217  g ml−1. It  was  concluded  that caffeoylquinic
acids,  the  major  components,  justiﬁed  98%  of  the  enzyme  inhibition  measured.
©  2016  Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This is an  open
he  CCaccess  article  under  t
ntroduction
The reduction of blood cholesterol level is one of the guidelines
f the European Society of Cardiology to reduce the risk of develop-
ng cardiovascular diseases (Backer et al., 2003), one of the highest
ause of death in Europe and also around the world (Nichols et al.,
014). Atherosclerosis is a disease in which atheromatous plaques
re formed inside arteries, triggering their hardening and narrow-
ng, limiting, the blood ﬂow. These plaques are formed essentially
y triacylglycerols, lipoproteins, cholesterol and foam cells (Niki,
011; Bentzon et al., 2014). Reduction of atherosclerosis by dimin-
shing the blood cholesterol level is one of the approaches for
ecreasing the risk of heart diseases (Gotto and Phill, 2011). This
ay  be achieved by decreasing diet cholesterol intake, as sometudies reported correlations between diet cholesterol intake and
lood cholesterol level (Houston et al., 2011; Dehghan et al., 2012),
hich can contribute for atherosclerosis-related diseases (Niki,
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reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2011). Besides a healthy diet (Reiner et al., 2011) cholesterol levels
can be decreased by reducing its biosynthesis through inhibition of
the enzyme HMG-CoA reductase (HMGR), involved in the choles-
terol biosynthetic pathway (Istvan and Deisenhofer, 2001), which
is the approach taken clinically by statins. Another approach is
the reduction in dietary cholesterol absorption through the block-
age of the cholesterol protein transporter (Niemann-Pick C1-like 1
protein – NPC1L1), in intestinal cells (Wang, 2007), which can be
accomplished by the drug ezetimibe (Vrablik et al., 2014). Hyper-
cholesterolemia can even be treated simultaneously by ezetimibe
and statins, one to reduce cholesterol absorption and the other to
inhibit its synthesis (Hamilton-Craig et al., 2010).
Physical activity with other lifestyle corrections, such as a nutri-
tionally balanced diet rich in fruits and vegetables, are naturally
effective factors for preventing the risk of cardiovascular diseases
(Rodriguez-Mateos et al., 2014). In fact, the effects of different
polyphenol-containing foods and beverages on health have been
analyzed in several studies that showed that fruit, vegetables, nuts
and plant-derived beverages, such juices and infusions/decoctions,
with a high antioxidant activity may  play an important role pre-
venting various disorders associated with oxidative stress, such as
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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ancer, cardiovascular and neurodegenerative diseases (Scalbert
t al., 2005; Wolfe et al., 2008). Evidence has been accumulated
n recent years on the diversity of bioactivities of components
f herbal decoctions or infusions, such as phenolic compounds
Al Shukor et al., 2013), namely the hypocholesterolaemic effect
Chen et al., 2008; Johari et al., 2015). Vernonia condensata Baker,
steraceae, commonly named in Brazil as “boldo-baiano”, “alumã”
r “ﬁgatil”, is a shrub probably native from Tropical Africa and
aken to Brazil in colonial times (Toyang and Verpoorte, 2013).
ernonia condensata is a species frequently referred by a number
f synonyms such as V. amygdalina Delile, V. bahiensis Toledo, V.
ylvestris Glaz. and after Robinson’s taxonomical revision of the
aleotropic species of tribe Vernonieae (1999) as Vernonanthura
ondensata (Baker) H. Rob. However Robinson’s classiﬁcation of the
ew World Vernonieae species, formerly named as Vernonia sensu
aker, into new genera has not generally been accepted (De Oliveira
t al., 2007). Authors consider that the taxonomical classiﬁcation
f the genus Vernonia Schreb is complex, yet unclear and needing
urther studies (Martucci et al., 2014). In Brazil, leaves of V. con-
ensata are often used to prepare beverages in the form of juices
r infusions/decoctions. Despite the numerous phytochemical and
harmacological studies carried out in species of Vernonia genus
Toyang and Verpoorte, 2013), only a few scientiﬁc articles have
een published concerning V. condensata, although recently it has
een reported that its ethanol extracts can be a source of bioac-
ive compounds with antioxidant activity (Da Silva et al., 2013).
here are also reports on the activity of this herb as hypolipidemic
nd hypocholesterolemic (Pizziolo et al., 2011). The current study
imed to evaluate the composition and the biological activity of
everages prepared from V. condensata leaves infusions and decoc-
ions in cholesterol-lowering permeation through the intestinal
arrier using Caco-2 cell monolayers, together with the inhibi-
ion of HMGR activity, in an attempt to contribute with a scientiﬁc
xplanation for the effect of these beverages on human health.
aterials and methods
lant material
Leaves of Vernonia condensata Baker, Asteraceae, Vernonieae,
ere collected from plants cultivated in the Garden of Medici-
al Plants of Universidade Estadual de Santa Cruz (Bahia, Brazil)
etween September and December of 2012. A voucher specimen
f this species was deposited in the Herbarium of this University
HUESC 16275).
everages preparation
Vernonia condensata leaves were prepared as infusions and
ecoctions, using 40 g of dry leaves in 400 ml  of distilled water.
or infusions the plant material was immersed in freshly boiled
ater during 10 min  and for decoctions the material was  boiled in
ater for 10 min. After cooling infusions and decoctions were ﬁl-
ered through a grade 1 Whatman paper and lyophilized to obtain
ried mixtures. The yield of dry material was 2.5% in infusions and
% in decoctions.
hemical analysis by HPLC-DAD and LC–MS
The analysis of the infusion and decoction was carried out by
PLC-DAD and the identiﬁcation and quantiﬁcation of their chem-
cal components, was accomplished using standards chlorogenic
cid (Sigma–Aldrich, Spain), cynarin (Sigma–Aldrich, Spain), lute-
lin and kampherol obtained from Sigma–Aldrich, Spain. Both the
xtract and the standards were analyzed using an Elite LaChrom®
WR  Hitachi liquid chromatograph equipped with a Column Ovenarmacognosia 26 (2016) 738–743 739
L-2300 and Diode Array Detector L-2455 (VWR, USA) (Falé et al.,
2013c). Standards of cynarin and chlorogenic acid, the main com-
ponents, were run under the same conditions using 0.1 mg  ml−1
solutions in methanol (Merck, Darmstdt, Germany). The extracts
were analyzed by HPLC injecting 25 l (1 mg ml−1) with an auto
injector, and using a gradient composed of solution A (0.05% tri-
ﬂuoroacetic acid), and solution B (methanol) as follows: 0 min, 80%
A, 20% B; 20 min  20% A, 80% B; 25 min, 20% A, 80% B. the ﬂow
was 1 ml  min−1 and the detection was carried out between 200
and 500 nm with a diode array detector. The column used was  a
LiChroCART® 250-4LiChrospher® 100 RP-8 (5 m)  column (Merck,
Darmstadt, Germany).
The LC–MS and LC–MS/MS analysis were carried out on a liquid
chromatograph Surveyor Plus Modular LC system connected to a
LCQ Duo ion trap mass spectrometer equipped with an electrospray
ionization (ESI) source, from Thermo Scientiﬁc (Bremen, Germany)
(Falé et al., 2013c). The extracts were analyzed by LC–MS/MS inject-
ing 25 l with a concentration of 10 mg  ml−1 and using a linear
gradient composed of solution A (1.0% formic acid), and solution
B (methanol) as follows: 0 min, 70% A, 30% B; 20 min  20% A, 80%
B; 25 min, 20% A, 80% B. The mass spectrometer was  operated in
both positive and negative ion modes in the range 120–1000 m/z,
and the parameters were adjusted in order to optimize the signal-
to-noise ratios (S/N) for the ions of interest. Brieﬂy, the nebulizing
and auxiliary gas (nitrogen) ﬂow rates were 40 and 20 (arbitrary
units) and the capillary temperature was  set to 250 ◦C. Collision
induced dissociation (CID) experiments were performed by isolat-
ing the ions within the ion trap and accelerating them in order to
suffer multiple collisions, with the background gas present in the
ion trap (helium) using a data dependent acquisition mode. The ions
of interest were activated by applying a percentage of a supplemen-
tary a.c. potential in the range of 0.75–1.75 Vp-p (peak-to-peak) to
the end cap electrodes of the ion trap at the resonance frequency
of the selected ion (referred to as the normalized collision energy,
NCE). The injection times were 50 ms  in a full scan and 200 ms  in an
MS/MS  scan. XcaliburTM software from thermo scientiﬁc was used
to acquire and process the data.
Toxicity tests
The toxicity of the V. condensata decoctions was analyzed by
thiazoyl tetrazolium bromide (MTT) (Sigma–Aldrich, Barcelona,
Spain) method using Caco-2 (ATCC#HTB37) and HepG2 (ATCC#HB-
8065) cell lines, according to Mosman method (Mosman, 1983).
Brieﬂy: Caco-2 and HepG2 were cultured in DMEM supplemented
with 10% FBS, 100 U ml−1 penicillin, 100 U ml−1 streptomycin, and
2 mM l-glutamine at 37 ◦C in an atmosphere with 5% CO2. The
medium was  changed every 48–72 h, and the cells were passaged
before reaching conﬂuence. Cytotoxicity studies were performed
in 96-well plates, exposing the cells for 24 h to several concen-
trations of the plant extracts in culture medium. The average and
standard deviation were calculated from 3 × 8 replicates for each
concentration.
In vitro digestion with gastric and pancreatic juices
The in vitro metabolism of the V. condensata decoction was stud-
ied by the method described in Porﬁrio et al. (2010).
Biological activities evaluation of Vernonia condensata decoction
The antioxidant activity was  determined by 2,2-diphenyl-1-
picrylhydrazyl (DPPH) (Sigma–Aldrich, Barcelona, Spain) method,
as described previously (Porﬁrio et al., 2010). Inhibition of
HMG-CoA reductase was  studied using a kit provided by Sigma
(Barcelona, Spain). The assay was performed as described by Falé
7 a de Farmacognosia 26 (2016) 738–743
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t al. (2013c) by quantifying NADPH at 0, 1, 2, 4 and 6 min  in reac-
ion mixtures containing different concentrations of V. condensata
ecoctions. The percentage of HMGR inhibition by each decoction
oncentration was calculated as: I (%) = 100–100 × (vsample/vcontrol),
here I is the percentage inhibition of enzyme, vsample is the ini-
ial rate of enzymatic reaction for the decoction and vcontrol is the
nitial rate for the control reaction in the absence of extract. The
C50 value was calculated and represents the concentration of the
ecoction that inhibited 50% of HMGR activity. Simvastatin, a com-
ercially available drug to lower cholesterol, was purchased from
anoﬁ-Aventis (Porto Salvo, Portugal) and used as a positive control.
ermeation studies
For the permeation of the beverage components and choles-
erol, Caco-2 cells, previously grown as described in Falé et al.
2014) were seeded in 12-well transwell plate inserts at a den-
ity of 2–4 × 104 cells/cm2. These inserts had 10.5 mm diameter and
.4 m pore size (BD FalconTM). The monolayers were formed till
onﬂuence was attained and then differentiated (21–26 days). The
edium was replaced every 24 h. The membranes were adequate to
ermeability studies when the transepithelial electrical resistance
TEER) was higher than 250  cm2. This value was measured with a
illicell ERS-2 V-Ohm Meter. To start the assay of the permeation of
he decoction components, the cells grown in the transwells plate
nserts were washed with HBSS (VWR International, Lisbon, Por-
ugal) and then 0.5 ml  of the decoction in HBSS (0.5 mg  of dried
ixture ml−1) were applied into the apical chamber. In the basolat-
ral chamber 1.5 ml  of HBSS were applied. The cells were in contact
ith the decoction during 6 h at 37 ◦C, 5% CO2. The solutions from
oth chambers were collected and 25 l aliquots were analyzed by
PLC-DAD as described. The permeation of the decoction compo-
ents was quantiﬁed in percentage of component detected in the
asolateral chamber relatively to quantity introduced in the apical
hamber per hour per Caco-2 cell monolayer area (cm2).
For the study of the effect of the V. condensata decoction in
holesterol permeation, the Caco-2 cells grown in transwell plate
nserts were washed with HBSS and 0.5 ml  of solution containing
ecoction (0.5 mg  dried mixture ml−1) plus cholesterol (2 mg  ml−1)
n HBSS was added to the apical chamber. In the basolateral cham-
er 1.5 ml  of HBSS were applied. The cells were in contact with this
olution during 6 h at 37 ◦C, 5% CO2. After this period the solutions
rom both chambers were collected and analyzed by HPLC-DAD.
5 l of each chamber were injected in the HPLC-DAD system
escribed, however the separation was carried in isocratic mode
sing 50% methanol plus acetonitrile for 15 min  with a ﬂow of
 ml  min−1. Detection of cholesterol was carried out at 210 nm.
he effect of ezetimibe (bought from MSD-SP Limited, Hertford-
hire, UK), a commercial drug to lower cholesterol, was analyzed
y introducing 100 mM dissolved in the culture medium in the api-
al chamber and allowed to be into contact with the cells, in the
resence of cholesterol, in the same concentration as used in the
ontrol. The permeation was quantiﬁed in percentage of cholesterol
rea detected in the basolateral chamber and inside the cells rel-
tively to quantity introduced in the apical chamber, measured as
rea in the HPLC-DAD system, converted into molarity (nmol) per
our per Caco-2 cell monolayer area (cm2). The cells were washed
ith HBSS, scraped and resuspended in HBSS. The cells were soni-
ated 5 × 10 s, centrifuged 10 min  at 5000 × g, and the supernatant
as analyzed by HPLC-DAD using the same method as described
efore.
For the study of the effect of the 24 h incubation of cells with
. condensata decoction in the cholesterol permeation, the Caco-2
ells grown in transwell plate inserts were in contact with 0.5 ml  of
he decoction in DMEM medium (0.5 mg  dried mixture/ml), during
4 h at 37 ◦C, 5% CO2. After this period the cells were washed withFig. 1. HPLC-DAD from decoctions of Vernonia condensata leaves. Peak number
refers to Table 1.
HBSS and cholesterol was  added to the apical chamber (2 mg/ml
HBSS). In the basolateral chamber 1.5 ml  of HBSS were applied.
The cells were in contact with the cholesterol during 6 h and the
solutions from both chambers were collected and analyzed by
HPLC-DAD using the isocratic mode. The same approach and con-
ditions were used to study the effect of ezetimibe in cholesterol
permeation. Triplicate assays were performed for each analysis.
Data analysis
All data analysis was  performed using Microsoft Excel 2010 and
the results were expressed as means ± standard deviation. Addi-
tional analysis of variance (ANOVA) was performed at a conﬁdence
level of p = 0.05 (Lison, 1968).
Results and discussion
Components of the herbal beverages
The beverages prepared by infusion and decoction of Vernonia
condensata leaves were analyzed by HPLC-DAD and their pheno-
lic compounds identiﬁed by LC–MS/MS. As the chromatograms of
infusions and decoctions were similar, having decoctions only a
higher quantity of all the chemical components, the study pro-
ceeded using only this beverage. The chromatogram obtained is
shown in Fig. 1 and the identiﬁed compounds are included in
Table 1.
As it can be seen in the HPLC chromatogram, most of the con-
stituents are caffeic acid derivatives (peaks 1–5, 7), only compound
number 6 was identiﬁed as a ﬂavonoid derivative.
The presence of chlorogenic acid and cynarin in the decoc-
tion was  conﬁrmed by HPLC-DAD and mass spectrometry using
the respective standards. Chlorogenic acid (3-caffeoylquinic acid,
peak number 2) is the main component of the decoction, followed
by dicaffeoylquinic acids. Mono and di-esters of caffeic acid with
quinic acid have been also detected in several Vernonia species (as
reviewed by Toyang and Verpoorte, 2013) and chlorogenic acid is
considered a biomarker of Asteraceae (Jaiswal et al., 2011). In other
species of this family, such as Cynara cardunculus, caffeoylquinic
acids are the infusion’s main components, and among them chloro-
genic acid and cynarin were also detected (Falé et al., 2013c).
Cytotoxicity, antioxidant activity and digestibility of the leaves V.
condensata decoction
Before initiating the permeation studies with the decoction
through the intestinal barrier, and the detection of the HMGR activ-
ity, the cytotoxicity of the herbal tea toward HepG2 and Caco-2 cells
lines was  evaluated. The decoction of V. condensata leaves showed
an IC50 of 0.58 mg ml−1 either in HepG2 or Caco-2 cells (Table 2). The
IC50 values obtained with the two cell lines tested were higher than
A.A. Arantes et al. / Revista Brasileira de Farmacognosia 26 (2016) 738–743 741
Table  1
Major constituents of decoctions from Vernonia condensata leaves. Identiﬁcation by LC–MS/MS, in negative ion mode and relative abundance of each compound (%) found in
the  HPLC-DAD chromatogram.
Peak
number
HPLC peak
Retention time
[M−H]−1
(m/z)
Fragment ions (m/z)
(Rel. Ab. %)
MS2
Compound Compound
(%)
Quantity
(g/mg)
1 7.5 353 259 (11), 179 (62), 173 (100), 135 (11) Caffeoylquinic acid 5 1.2a
2 8.6 353 192 (10), 191 (100), 179 (12), Chlorogenic acid 34 7.8
3  12.4 515 353 (100), 335 (11), 299 (5), 255 (5), 203 (6), 191 (5),
179 (9), 173 (12)
Dicaffeoylquinic acid 8 2.7b
4 12.9 515 353 (100), 203 (1), 191 (3), 179 (2), 173 (1) Dicaffeoylquinic acid 12 4.5b
5 13.4 515 353 (100), 335 (3), 191 (9), 179 (1) Cynarin 9 3.2
6  14.0 461 381 (5), 369 (2), 357 (8) 355 (2), 327 (4), 285 (100) Luteolin 7 –
7  14.5 515 353 (100), 335 (2), 317 (6), 299 (21), 255 (8), 204 (3),
203 (17), 179 (3), 173 (7)
Dicaffeoylquinic acid 11 4.0b
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the intestinal barrier of compounds taken orally (from diet or
drugs), as these cells can differentiate on polycarbonate mem-
branes, acquiring a phenotype with tight junctions, microvilli and a
number of enzymes and transporters characteristic of enterocytes
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)a Equivalent of chlorogenic acid.
b Equivalents of cynarin.
he established limit of IC50 value (0.1 mg  ml−1), that is considered
sually as toxic to human cell lines (Oonsivilai et al., 2007).
These results are in agreement with those previously found in
ivo studies, which demonstrated that the tea from leaves of V. con-
ensata has no oral acute toxicity in mice (Monteiro et al., 2001).
queous extracts of other Asteraceae species, such as Cynara car-
unculus, with similar composition to V. condensata decoctions, also
id not shown any toxicity to Caco-2 and HeLa cell lines (Falé et al.,
013c).
As no cytotoxicity was detected in the decoction of V. condensata
eaves, the effect of the in vitro digestive process in this beverage
ould be evaluated. So, the decoction was subjected to artiﬁcial gas-
ric and pancreatic juices simulating the conditions in the stomach
nd small intestine, respectively. The changes in the chemical com-
osition of the decoction were followed by analyzing the digested
xtract hourly by HPLC. As it can be observed in Fig. 2, even after
 h of digestion with gastric and pancreatic juices, the composi-
ion remained similar to the initial beverage. This suggests that the
ecoction components are stable under the gastric and pancreatic
H conditions and are not substrates of the enzymes in the gastroin-
estinal tract. These ﬁndings are in agreement with others reported
or this class of compounds (Bouayed et al., 2012; Falé et al., 2013c,
014).
The antioxidant activity, quantiﬁed by the free radical DPPH
ethod, revealed that 20.0 ± 0.6 g ml−1 of the decoction of V. con-
ensata leaves had the capacity to extinguish 50% of the compound
bsorption (Table 2). The EC50 value for the antioxidant activity
f V. condensata decoction was in the same magnitude of that
btained for the commercial antioxidant BHT (15.7 ± 0.2 g ml−1)
Mata et al., 2007). Previous studies concerning the detection of
able 2
ecoction of Vernonia condensata leaves – toxicity in HepG2 and Caco-2 cells lines
IC50 g ml−1) in vitro digestion and antioxidant activity (EC50 g ml−1).
Toxicity
HepG2 cells IC50 = 586.3 ± 6.5
Caco-2 cells IC50 = 580.0 ± 10.0
Digestiona
Pepsin No modiﬁcation
Pancreatin No modiﬁcation
Antioxidant activityb
V. condensata EC50 = 20.0 ± 0.6
BHT EC50 = 15.7 ± 0.2c
a Digestion carried out using pepsin at pH 1.2 during 4 h and pancreatin at pH 8.0
uring 4 h (Porﬁrio et al., 2010).
b Antioxidant activity was measured using DPPH solution incubated for 30 min
n  the presence of different extract concentration and the absorbance was read at
17 nm against a blank (Porﬁrio et al., 2010).
c Mata et al. (2007).the in vitro antioxidant activity in ethanol extracts and fractions
obtained from V. condensata leaves have shown that this species has
potential to be an important source of antioxidant compounds (Da
Silva et al., 2013). The antioxidant activity studied here conﬁrms
this conclusion and suggests that the decoction of V. condensata
leaves has a good capacity to capture electrons inside the cell.
Effect of the decoction in cholesterol permeation through Caco-2
cells
Caco-2 monolayers can be used to study the permeation throughB
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Fig. 2. HPLC chromatograms of the decoction of Vernonia condensata leaves before
and after digestion with artiﬁcial gastric and pancreatic juices (initial time; ----
after 4-h incubation with artiﬁcial juices): (A) in vitro gastric digestion; (B) in vitro
pancreatic digestion. *Indicates the pancreatin peak.
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Table 3
Permeation of cholesterol (%) and HMGR activity measured as IC50 of the two major
phenolic compounds from Vernonia condensata decoction. Distilled water was used
as  a negative control (0% inhibition). Ezetimibe and simvastatin were used as positive
controls. All data are presented as the mean ± SD of triplicates.
Intracellular Basolateral
Cholesterol permeation
Control 35.1 ± 7.2a 21.4 ± 3.1a
V. condensata 6 h 10.4 ± 1.4b 23.8 ± 0.5a
V. condensata 24 h 4.4 ± 3.2c 13.2 ± 8.6a,b
Ezetimibe 100 M 18.9 ± 1.9d 5.2 ± 3.1b
Chlorogenic acid and cynarin permeation
Chlorogenic acid 13.0 ± 0.2a 26.7 ± 3.0b
Cynarin 12.0 ± 1.1a 15.8 ± 6.1a
HMGR activity
V. condensata 271.7 ± 24.1 g ml−1
Chlorogenic acid 12.9 ± 0.5 Me
Cynarin 9.1 ± 0.4 Me
Simvastatin 0.47 ± 0.04 Me
Superscript letters (a–d) correspond to values in the same column that can be con-42 A.A. Arantes et al. / Revista Brasileir
Hidalgo et al., 1989). This system has been recognized by FDA
s appropriate to study permeation of drugs (Hu et al., 2004). As
he decoction of V. condensata leaves was not toxic to Caco-2 cells
nd no changes in the chemical composition were noticed after the
n vitro digestion, the permeation studies were initiated by intro-
ucing 0.5 mg  ml−1 of decoction in the apical cell culture medium,
nd allowed to be into contact with the cells for 6 and 24 h. The
ontrol had only cholesterol at a concentration of 5 mM and the test
ells contained cholesterol together with the V. condensata decoc-
ion at a concentration of 0.5 mg  ml−1. Cholesterol was  measured
nside the cells and in the baso-lateral compartment. Ezetimibe, the
rug used to reduce cholesterol absorption from the diet, was  also
ested as a positive control at a concentration of 100 M (Feng et al.,
010). The permeation of cholesterol to the basolateral compart-
ent of Caco-2 cells, when the extract was into contact with these
ells for 6 h, was not modiﬁed relatively to the control. Infusions
rom other Asteraceae species containing mainly chlorogenic acid
nd dicaffeoylquinic acids, like those of Cynara cardunculus, did not
nhibit the transport of cholesterol through Caco-2 cell monolayers
hen the test was carried out for 6 h (Falé et al., 2014). When the
tudy was prolonged for 24 h, that is when the extract was into
ontact with the cells for 24 h and cholesterol was then applied
nd quantiﬁed afterwards, a lowering tendency could be noticed
n the cholesterol level on the basolateral compartment of the
ells, although not statistically signiﬁcant at 95% conﬁdence level
p = 0.05). When analyzing the intracellular value of cholesterol,
t can be seen that the V. condensata decoction reduced its level,
eing the differences statistically signiﬁcant (p = 0.05). Ezetimibe
nhibited both the permeation of cholesterol to the basolateral com-
artment and to inside the cell. The reduction in the permeation of
holesterol can be associated with the down-regulation of mRNA
iemann-Pick Like 1 protein (NPC1L1) that promotes the transport
f cholesterol inside the cells as well as with other membrane trans-
orter proteins all involved either in the uptake or with the efﬂux
f cholesterol from the cell (Liang et al., 2015).
ermeation of phenolic compounds present in the tea and
nhibition of HMRG activity
To have any effect on the enzyme activity inside the cells it is
ecessary that the active phenolic compounds present in V. con-
ensata decoction permeate the intestinal barrier. In the current
tudy the decoction was introduced in the culture medium for
4 h at a concentration of 0.5 mg  ml−1. In the beginning and at the
nd of the experiment, aliquots were withdrawn and analyzed by
PLC-DAD. The compounds detected in the basolateral compart-
ent were chlorogenic acid and cynarin. The permeation values
hrough the intestinal barrier simulated by Caco-2 cells were 26%
nd 15.8%, for chlorogenic acid and cynarin, respectively (Table 3).
Similar permeation results have been found in a study car-
ied out with infusions of C. cardunculus (Falé et al., 2013b). A
mall amount of these compounds, around 10%, were also detected
nside the cells (Table 3). Previous studies about chlorogenic perme-
tion though Caco-2 cells indicated that this permeation is highly
ependent on the extract composition (Falé et al., 2013a; Zhai et al.,
015).
The inﬂux of the phenolic compounds to the cell interior
ollowed by the efﬂux to the basolateral compartment allow
hese compounds to enter the bloodstream and reach different
rgans, especially the liver where they may  inhibit cholesterol
iosynthesis through the inhibition of the enzyme HMGR. As
hown in Table 3 the decoction of V. condensata leaves also inhibits
he activity of HMGR with an IC50 of 271 g ml−1. This suggests
hat the extract can act as a cholesterol reducing agent, probably
y a statin-like mechanism. In fact, both main compounds, chloro-
enic acid and cynarin, inhibit HMGR activity, even if their IC50sidered statistically different (p = 0.05).
e Falé et al. (2013b).
values were lower than the commercial hypocholesterolemic drug
simvastatin (Table 3). The presence of chlorogenic acid and cynarin
in the extract can explain 48% of the IC50 value, the remaining
activity can be ascribed to the other phenolic acids derivatives, as
well as to the ﬂavonoid derivatives containing in the decoction.
Calculating the activity of the other phenolic compounds, based
on the inhibition value determined for the standards that were
structurally similar, 98% of the activity seems to be explained
by the identiﬁed compounds. Recently, anti-HMGR activity has
also been detected in other plant aqueous extracts (Falé et al.,
2013b, 2014). Moreover, chlorogenic acid was recognized as an
HMGR inhibitor (Falé et al., 2014; Iqbal et al., 2014) and docking
studies proved that this molecule can ﬁt within the active site of
the enzyme (Navarro-Gonzalez et al., 2014), indicating that this
may be one of the procedures by which chlorogenic acid inhibits
cholesterol biosynthesis. On the other hand, cynarin, dicaffeoyl
quinic acid seems to be a stronger HMGR inhibitor comparatively
to the monocaffeoyl quinic acid, chlorogenic acid.
In conclusion, beverages prepared by infusion and decoction of
V. condensata leaves have IC50 values 5 times above the toxicity
limit and showed antioxidant and anti-HMGR activities, and their
bioactive components seem to be stable in conditions similar to
the gastrointestinal tract. The main compounds, chlorogenic acid
and cynarin, are absorbed through Caco-2 cells monolayers that
simulated the intestinal barrier. Our results also suggest that the
beverages may  reduce dietary cholesterol absorption to a small
extent. The present report may  explain and provide scientiﬁc
ground for the molecular understanding of the health beneﬁts of the
use of V. condensata decoctions to prevent hypercholesterolemia.
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